191 77 (Capecitabine 500 mg)

Pill imprint 191 77 has been identified as Capecitabine 500 mg.

Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; pancreatic cancer; stomach cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Capecitabine

Imprint:

191 77

Strength:

500 mg

Color:

Peach

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antimetabolites

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Teva Pharmaceuticals USA Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.